Periodic Reporting for period 1 - ParkIFNAR (Soluble IFNAR2 in Parkinson's disease and its role in the regulation of IFNβ in a neuroinflammatory context.)

Over 1.2 million people in Europe alone suffer from Parkinsonian disorders (PD), and it has a rising prevalence. This neurodegenerative condition led to decreased motor activity and other complications including cognitive impairment. Current medications for patients are...